All of the following are monoclonal antibodies against CD-20 except :
Rituximab, Ofatumumab, Ocrelizumab & Obinutuzumab are monoclonal antibodies against Cd-20.
Brentuximab acts against CD30.
Rituximab
Ofatumumab
Ocrelizumab
Brentuximab